Caribou Biosciences, Inc. Common Stock (CRBU)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Caribou Biosciences, Inc. Common Stock (CRBU) is listed on Nasdaq, where it has traded since July 23, 2021.
- Listed On
- Nasdaq
- Listed Since
- July 23, 2021
- Employees
- 97
- Market Cap
- $133M
About Caribou Biosciences, Inc. Common Stock
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 132 institutions reported holding CRBU, with 48.4 million shares worth $84.7 million in aggregate. The largest reported holder was BlackRock, with 7.8 million shares worth $13.8 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 7,815,843 | $14M | Added 264.7% |
| Vanguard | 5,492,573 | $10M | Added 26.1% |
| Pfizer | 4,690,431 | $8M | Unchanged |
| Mackenzie Financial | 3,650,796 | $6M | Added 287.23% |
| Renaissance Technologies | 2,773,545 | $5M | Added 7.07% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CRBU?
Caribou Biosciences, Inc. Common Stock (CRBU) is listed on Nasdaq, where it has traded since July 23, 2021.
Who are the largest institutional holders of CRBU?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CRBU were BlackRock, Vanguard and Pfizer.
How many institutions own CRBU?
132 institutions reported a position in CRBU for the quarter ended June 30, 2026, worth $84.7 million in total.
Did institutions buy or sell CRBU last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CRBU.
Every reported institutional holder, plus insider and congressional trades in CRBU, on SentiSense.